Associated Papers
Structural Insights into Protein Mutations Related to Autism Spectrum Disorders: A Systematic Review.
Das MR et al.
Acs Chemical Neuroscience, 2025
Autism Spectrum Disorder: The Cerebellum, Genes, and Pathways.
D'Mello SR
Neurology International, 2025
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population.
Arun AS et al.
The Pharmacogenomics Journal, 2025
Analyses of Human Genetic Data to Identify Clinically Relevant Domains of Neuroligins.
Lehr AW et al.
Genes, 2024
Regulation of NLGN3 and the Synaptic Rho-GEF Signaling Pathway by CDK5.
Jeong J et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2023
The Potential Role of AMPA Receptor Trafficking in Autism and Other Neurodevelopmental Conditions.
Niescier RF et al.
Neuroscience, 2021
Pathogenic paternally inherited NLGN4X deletion in a female with autism spectrum disorder: Clinical, cytogenetic, and molecular characterization.
Kopp N et al.
American Journal of Medical Genetics. Part A, 2021
An Autism-Associated Mutation Impairs Neuroligin-4 Glycosylation and Enhances Excitatory Synaptic Transmission in Human Neurons.
Cast TP et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2021
Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction.
Cheffer A et al.
Molecular Autism, 2020
Autism-associated variants of neuroligin 4X impair synaptogenic activity by various molecular mechanisms.
Yumoto T et al.
Molecular Autism, 2020
Modeling neuronal consequences of autism-associated gene regulatory variants with human induced pluripotent stem cells.
Ross PJ et al.
Molecular Autism, 2020
Neuroligins and Neurodevelopmental Disorders: X-Linked Genetics.
Nguyen TA et al.
Frontiers in Synaptic Neuroscience, 2020
Autism Spectrum Disorder and miRNA: An Overview of Experimental Models.
Schepici G et al.
Brain Sciences, 2019
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons.
Marro SG et al.
Neuron, 2019
Glutamatergic synapses in neurodevelopmental disorders.
Moretto E et al.
Progress in Neuro-psychopharmacology & Biological Psychiatry, 2018
Functional significance of rare neuroligin 1 variants found in autism.
Nakanishi M et al.
Plos Genetics, 2017
Functions of synapse adhesion molecules neurexin/neuroligins and neurodevelopmental disorders.
Cao X et al.
Neuroscience Research, 2017
Pathogenic mechanism of an autism-associated neuroligin mutation involves altered AMPA-receptor trafficking.
Chanda S et al.
Molecular Psychiatry, 2016
Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.
Nelson SB et al.
Neuron, 2015
Autism-associated mutation inhibits protein kinase C-mediated neuroligin-4X enhancement of excitatory synapses.
Bemben MA et al.
Proceedings of the National Academy of Sciences of the United States of America, 2015
Mouse models of mutations and variations in autism spectrum disorder-associated genes: mice expressing Caps2/Cadps2 copy number and alternative splicing variants.
Sadakata T et al.
International Journal of Environmental Research and Public Health, 2013
Mutation screening in the Greek population and evaluation of NLGN3 and NLGN4X genes causal factors for autism.
Volaki K et al.
Psychiatric Genetics, 2013
Identification of Four Novel Synonymous Substitutions in the X-Linked Genes Neuroligin 3 and Neuroligin 4X in Japanese Patients with Autistic Spectrum Disorder.
Yanagi K et al.
Autism Research and Treatment, 2012
An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus.
Etherton MR et al.
The Embo Journal, 2011
A substitution involving the NLGN4 gene associated with autistic behavior in the Greek population.
Pampanos A et al.
Genetic Testing and Molecular Biomarkers, 2009
Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist.
Lintas C et al.
Journal of Medical Genetics, 2009
Familial deletion within NLGN4 associated with autism and Tourette syndrome.
Lawson-Yuen A et al.
European Journal of Human Genetics : Ejhg, 2008
Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility.
Suárez-Rama JJ et al.
Journal of Psychiatric Research, 0